Researchers conducted an evaluation study to see how well the Abbott BinaxNOW rapid antigen test worked for finding SARS-CoV-2, the virus that causes COVID-19. The study took place at two community-based testing sites in Pima County, Arizona, and involved people who came to those sites for testing. The specific results of the test's performance, such as its accuracy compared to other tests, were not reported in the available information. This means we do not know from this report how many cases it correctly identified or missed. The report also did not mention any safety concerns related to using the test. The main reason to be careful is that without the actual results, we cannot draw any conclusions about whether this test is a good option for community testing. This appears to be an early report that simply notes an evaluation was done. Readers should understand that this is not a complete study with findings they can use. It highlights that research is ongoing to check how tests work outside of controlled labs, but we need to wait for the full results to know more.
BinaxNOW Rapid Antigen Test Performance Evaluated at Arizona Community Testing SitesResearchers evaluated a rapid COVID-19 test at two community sites in Arizona
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note: Preliminary report on BinaxNOW test lacks performance data; await full publication.
An evaluation study assessed the performance of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection. The study was conducted at two community-based testing sites in Pima County, Arizona, involving persons presenting for testing. The specific sample size was not reported, and no comparator test was detailed in the available report.
The primary outcome was the performance of the BinaxNOW test. However, the main results, including sensitivity, specificity, exact numbers, effect sizes, confidence intervals, or p-values, were not reported. The direction of any findings was also not specified.
No information on safety, adverse events, or tolerability was provided. The report did not list specific study limitations, and funding sources or potential conflicts of interest were not disclosed. The practice relevance was not reported. Given the incomplete nature of this preliminary report, clinicians should await full, peer-reviewed publication of the methodology and results before drawing conclusions about test performance in community settings.
What this means for you:
An evaluation of a rapid COVID test was done, but the results are not yet available. More on SARS-CoV-2 infection
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders
Clozapine users faced higher risk of severe COVID-19 in large study
A meta-analysis of 155,945 outpatients with severe mental disorders found that clozapine users had a higher rate of SARS-CoV-2 infection com…
A massive analysis of over 155,000 people found that those taking clozapine had higher rates of infection and worse outcomes from COVID-19.
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial
Metformin Cuts Long Covid Risk by 40%
This randomized controlled trial in 1323 non-hospitalized adults with SARS-CoV-2 infection evaluated metformin, fluvoxamine, or ivermectin v…
A common diabetes pill taken early in Covid infection cuts the odds of developing long-term symptoms by 40%, offering new hope for millions.
Observational cohort study on SARS-CoV-2 evolution in immunocompromised patients
Long COVID Virus Changes Shape Inside Severely Ill Patients, Study Finds
This observational cohort study analyzed longitudinal SARS-CoV-2 genomes from 91 immunocompromised patients with COVID-19.
When the virus lingers too long in very sick patients, it changes in unpredictable ways, highlighting the need for stronger treatments.
Systematic review synthesizes immune and genetic factors in African SARS-CoV-2 populations
Why Africa saw milder COVID-19
This narrative synthesis reviews 40 studies from African settings regarding SARS-CoV-2 infection.
Africa saw milder COVID-19 because unique genes and immune defenses helped people fight the virus without getting severely sick.
View Original Abstract ↓
This report describes the performance of the BinaxNOW rapid antigen test on specimens collected from persons at two community testing sites in Pima County, Arizona.
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
FDA Approves Linezolid Injection for Gram-Positive Infections Including Pneumonia and Skin Infections
FDA approves new antibiotic injection for serious bacterial infections
The FDA approved linezolid injection for nosocomial pneumonia, community-acquired pneumonia, complicated skin infections, and vancomycin-res…
The FDA approved linezolid injection for treating serious infections like pneumonia and skin infections caused by certain bacteria, includin…
Intrawound vancomycin powder reduces postoperative infection risk (OR 0.59) in high-risk fracture fixation cases
Vancomycin Powder May Reduce Infections After High Risk Fractures
This meta-analysis of 3185 patients found that intrawound vancomycin powder significantly reduced postoperative infection rates (OR 0.59; 95…
A review of data suggests that using vancomycin powder in wounds may lower infection rates for patients with serious bone fractures.
Risk-adapted HLA delisting and imlifidase enable deceased-donor kidney transplantation for highly sensitized candidates
New guide helps transplant kidneys for hardest-to-match patients
This expert consensus provides a practical guideline for managing highly sensitized adult patients on the waitlist for deceased-donor kidney…
A new expert guide shows how to safely transplant kidneys into highly sensitized patients who have few options left.
Regenerative endodontic procedures may lead to unusual root morphology in immature teeth
Regenerative procedures can lead to unusual tooth root growth
This case report with literature review describes 2 immature teeth with pulp necrosis secondary to dens evaginatus treated with regenerative…
A new look at dental treatments shows that while some procedures save teeth, they can sometimes cause unexpected changes in how roots grow.
From Other Specialties
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.